We are dedicated to helping physicians improve outcomes for patients with metastatic cancer by delivering advanced diagnostic testing solutions.
Joined February 2016
- Tweets 2,189
- Following 778
- Followers 2,000
- Likes 225
1,078 Photos and videos
In case you haven’t already, check out Biocept on our other social media platforms! #GetCancerAnswers
LinkedIn:
linkedin.com/company/Biocept
Facebook:
facebook.com/biocept
Instagram:
instagram.com/mybiocept
4
3
Happy Holidays from the Biocept team! We wish you and your family all the best this holiday season and upcoming year! #CNSide #GetCancerAnswers
1
375
“When you’re diagnosed with a brain tumor, it’s not just a chapter in your life.” – Dan Zappa
Together, let’s continue to invest in hope for patients with LM and brain tumors. Visit abta.org/hope to donate this holiday season.
@theABTA #GetCancerAnswers
284
For more information on how to order CNSide™ Next-Generation Sequencing testing on cerebrospinal fluid, please visit biocept.com/order-a-test.
Today is #GivingTuesday. Together, let’s invest in hope for patients with leptomeningeal metastasis and brain tumors.
In the spirit of holiday giving, donate now to @theABTA: bit.ly/2022GTSocial
#GetCancerAnswers
1
2
Visit Biocept’s booth (#512) at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology and learn about the clinical poster on mutant p53 positive glioblastoma cells being presented on Friday, 11/18 from 7:30-9:30 PM ET. #CNSide #GetCancerAnswers #SNO2022
1
Visit Biocept’s booth (#512) at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology and learn about the HER2 Flip clinical poster being presented on Friday, 11/18 from 7:30-9:30 PM ET. @NeuroOnc #GetCancerAnswers #SNO2022
2
2
#FlashbackFriday to our Biocept luncheon with @Duffsdoggz to celebrate the @Padres advancing in the playoffs! Let’s go Padres!
1
1
#InTheNews: Biocept Expands Commercial Offering of CNSide™ Assay to Most Cancers that Metastasize to the Central Nervous System
Learn more: ir.biocept.com/news-releases…
#CNSide #GetCancerAnswers
2
2
3
Join our CNSide webinar on October 14th at 1:00pm ET, featuring key opinion leaders Priya U. Kumthekar, MD and Seema A. Nagpal, MD.
Register here: event.choruscall.com/mediafr…
#CNSide #GetCancerAnswers
1
3
Did you know? Biocept initiated a clinical trial, the FORESEE Study, for patients with breast or non-small cell lung cancer (NSCLC) who have suspected or confirmed leptomeningeal metastases (LM).
Learn more: biocept.com/clinical-trials/
#CNSide #GetCancerAnswers #FORESEEStudy
1
2
Science and creativity go hand in hand. It’s no surprise our Biocept team can paint like Van Gogh. 😊
#teambuilding #ThrowbackThursday
2
Today is Stand Up To Cancer Day. Join us in bringing awareness. We’re stronger together.
#StandUpToCancer #GetCancerAnswers #CNSide
1
#IntheNews: Plus Therapeutics Awarded $17.6 Million from State of Texas. The funding will support the ReSPECT-LM Study and development of Rhenium-186 NanoLiposome (186RNL) for leptomeningeal metastases. Learn more on @plustxinc:
ir.plustherapeutics.com/news…
#ClinicalTrial #CNSide
2
2
We had a fantastic time engaging with the neuro-oncology community again at the 2022 Annual Conference on CNS Clinical Trial and Brain Metastases and exploring the city of Toronto! Thank you again to @NeuroOnc and @ASCO for hosting. #GetCancerAnswers #CNSide #brainmets
1
2
6